BiotechTube
Home/Opthea/Kathy Connell
KC

Kathy Connell

Non-Executive Director and Chair of Remuneration Committee

Opthea

Therapeutic Areas

Rare Disease (Pulmonary)Ophthalmology

Opthea Pipeline

DrugIndicationPhase
Sozinibercept (OPT-302)Lymphangioleiomyomatosis (LAM)Phase 2 (Planned)

Leadership Team at Opthea

JM
Jeremy M. Levin
Chairman of the Board
SM
Stuart Mudge
Chief Operating Officer
MG
Mike Gerometta
Chief Technology Officer
HG
Hamish George
Chief Finance Officer
View full Opthea profile